Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 11/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20640946 | 0.85 | PTGS2 (0.40) | NFE2L2CYP1A2 | |
| SCHEMBL320615 | 0.83 | NFE2L2 (0.62) | NFE2L2MAOBCYP1A2RELACYP2D6 | |
| SCHEMBL4090323 | 0.83 | NFE2L2 (0.62) | NFE2L2MAOBCYP1A2RELACYP2D6 | |
| SCHEMBL20640938 | 0.78 | NFE2L2 (0.45) | NFE2L2 | |
| SCHEMBL20640997 | 0.77 | NFE2L2 (0.52) | NFE2L2 | |
| SCHEMBL15051245 | 0.77 | NFE2L2 (0.54) | NFE2L2RELA | |
| SCHEMBL15051244 | 0.77 | NFE2L2 (0.54) | NFE2L2RELA | |
| SCHEMBL15094203 | 0.76 | HSD11B1 (0.50) | RELA | |
| SCHEMBL15539237 | 0.76 | CHAT (0.44) | NFE2L2MAOBCYP1A2RELACYP2D6 | |
| SCHEMBL5319574 | 0.76 | CHAT (0.44) | NFE2L2MAOBCYP1A2RELACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3704097-A1 | BICYCLIC SULFONES AND SULFOXIDES AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2020-09-09 | — | — | EP | disclosed |
| EP-3652178-A1 | BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF | H. Hoffnabb-La Roche Ag (CH) | 2020-05-20 | — | — | EP | disclosed |
| WO-2019012063-A1 | BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2019-01-17 | — | — | WO | disclosed |